Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 14, 2023, Tactile Systems Technology, Inc. (the "Company," "we," "us" or "our") announced that its Board of Directors has appointed Elaine M. Birkemeyer as the Company's Chief Financial Officer, effective March 20, 2023, to succeed Brent Moen, who is retiring as our Chief Financial Officer as previously disclosed.

Ms. Birkemeyer, age 48, will join the Company from UnitedHealth Group Incorporated ("UnitedHealth"), where she has served as Chief Financial Officer, Optum Care Solutions since May 2021. Prior to that, she held various other roles with UnitedHealth, including Chief Financial Officer, Rally Health from March 2020 to May 2021, Senior Vice President, Optum Corporate Finance from February 2017 to March 2020, and Vice President, Optum Operations Finance from July 2014 to February 2017. Previously, Ms. Birkemeyer held various positions with Best Buy Co., Inc., including Senior Director, Strategy and Business Planning, Senior Finance Director and Senior Finance Manager. Ms. Birkemeyer has over 26 years of experience in finance, accounting, financial analysis, strategy and business planning. Ms. Birkemeyer holds an M.B.A. from Northwestern University 's Kellogg School of Management and a B.S. in Economics from the University of Pennsylvania's Wharton School.

There are no arrangements or understandings between Ms. Birkemeyer and any other persons pursuant to which she was appointed our Chief Financial Officer. There are no family relationships between Ms. Birkemeyer and any of our directors or executive officers, and Ms. Birkemeyer does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Ms. Birkemeyer accepted a written offer letter from us establishing her compensation as our Chief Financial Officer. Pursuant to the offer letter, Ms. Birkemeyer's initial compensation will consist of the following:

· An initial annualized base salary of $400,000 per year, which will be subject


   to review by the Compensation and Organization Committee of our Board of
   Directors after 2023 in accordance with its practices.

· Ms. Birkemeyer will be eligible to receive an annual cash bonus under the


   Company's bonus plan in a target amount equal to 55% of her base salary
   prorated for 2023.

· Ms. Birkemeyer will receive equity awards under our 2016 Equity Incentive Plan,

to be granted on the second business day following our release of earnings for

the first fiscal quarter of 2023:

o a sign-on equity award of $250,000, in the form of restricted stock units

("RSUs") that will vest in thirds over the first three anniversaries of the


   date of grant; and

o an equity award of $600,000, with 60% of such award issued in RSUs that will

vest in thirds over the first three anniversaries of the date of grant, and 40%

of such award issued in performance stock units that will be earned and vested

over three years consistent with performance share units granted to the

Company's other executive officers in 2023.

· Ms. Birkemeyer will be entitled to participate in all employee benefit plans


   and programs to the extent that she meets the eligibility requirements for each
   individual plan or program.

· Ms. Birkemeyer will enter into our standard Confidentiality, Assignment of


   Intellectual Property and Restrictive Covenants Agreement (the "Restrictive
   Covenants Agreement"), and then become a participant in our Executive Employee
   Severance Plan (the "Executive Severance Plan").

The foregoing summary of the offer letter does not purport to be complete and is qualified in its entirety by reference to the full text of the offer letter, a copy of which is filed as Exhibit 10.1 to this report and is incorporated herein by reference. A summary of the Executive Severance Plan is included in our Proxy Statement for our 2020 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission on March 19, 2020 under "Executive Compensation - Potential Payments Upon Termination or Change in Control - Severance Plan." The Executive Severance Plan was filed as Exhibit 10.2 to our Quarterly Report on Form 10-Q filed November 5, 2018 and is incorporated herein by reference as Exhibit 10.2. A summary of the Restrictive Covenants Agreement is included in our Proxy Statement for our 2020 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission on March 19, 2020 under "Executive Compensation - Potential Payments Upon Termination or Change in Control - Severance and Restrictive Covenant Arrangements." The form of Restrictive Covenants Agreement was filed as Exhibit 10.3 to our Quarterly Report on Form 10-Q filed November 5, 2018 and is incorporated herein by reference as Exhibit 10.3.

Item 7.01. Regulation FD Disclosure.

On March 14, 2023, the Company issued a press release related to the transition discussed in Item 5.02 above. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.

© Edgar Online, source Glimpses